Wen-Han Feng

6PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Cardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis.

Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin

|May 14, 2022
Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.

Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin

|May 12, 2021
Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy.

Ming-Yun Ho, Po-Wei Chen, Wen-Han Feng

|Jul 09, 2020
Effects of Lipids and Lipoproteins on Mesenchymal Stem Cells Used in Cardiac Tissue Regeneration.

Yi-Hsiung Lin, Lin Kang, Wen-Han Feng

|Jun 05, 2020
P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Po-Wei Chen, Wen-Han Feng, Ming-Yun Ho

|May 04, 2019
The effects of secondary prevention after coronary revascularization in Taiwan.

Wen-Han Feng, Chun-Yuan Chu, Po-Chao Hsu

Pageof 1

Frequent Collaborators

3 joint publications

Yi-Hsiung Lin

2 joint publications

Po-Wei Chen

2 joint publications

Hung-I Yeh

2 joint publications

Chih-Sheng Chu